INFLAMMATORY CYTOKINES IN CYSTIC-FIBROSIS LUNGS

被引:565
作者
BONFIELD, TL
PANUSKA, JR
KONSTAN, MW
HILLIARD, KA
HILLIARD, JB
GHNAIM, H
BERGER, M
机构
[1] CASE WESTERN RESERVE UNIV,DEPT PEDIAT,CLEVELAND,OH 44106
[2] CASE WESTERN RESERVE UNIV,DEPT MED,CLEVELAND,OH 44106
关键词
D O I
10.1164/ajrccm.152.6.8520783
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Chronic pulmonary infection with Pseudomonas aeruginosa continues to be the major cause of morbidity and mortality in cystic fibrosis (CF). Several characteristics of CF, including the excessive influx of neutrophils into the airways, cachexia, and hyperglobulinemia, could reflect the effects of cytokines, such as interleukin-1 (IL-1), IL-6, IL-8, and tumor necrosis factor (TNF-alpha). We hypothesized that these pro-inflammatory cytokines, produced by alveolar macrophages in response to pseudomonas and/or other microorganisms, promote the destructive inflammatory process in the lung. We evaluated bronchoalveolar lavage (BAL) fluid and BAL macrophages from 22 CF patients and 13 healthy control (HC) subjects, measuring soluble TNF-alpha, IL-1 beta, IL-6, and IL-8 and the regulatory molecules TNF soluble receptor (TNF-sR), IL-1 receptor antagonist (IL-1 Ra), and IL-10 (cytokine synthesis inhibitory factor). Levels of the proinflammatory cytokines were higher in CF versus HC BAL (p less than or equal to 0.05 for IL-1, TNF, and IL-8; p = 0.06 for IL-6). In contrast, HC BAL contained significantly more IL-10 than CF BAL (p < 0.05), but TNF-sR and IL-1 Ra were similar. Immunocytochemistry demonstrated a higher percentage of CF than control BAL macrophages expressing intracellular cytokines (p < 0.05). Thus, enhanced macrophage production of proinflammatory cytokines and decreased production of the regulatory molecule IL-10 may have important roles in the pathogenesis of CF lung disease.
引用
收藏
页码:2111 / 2118
页数:8
相关论文
共 36 条
  • [1] BECKER S, 1991, J IMMUNOL, V147, P4307
  • [2] PROTEASE-ANTIPROTEASE IMBALANCE IN THE LUNGS OF CHILDREN WITH CYSTIC-FIBROSIS
    BIRRER, P
    MCELVANEY, NG
    RUDEBERG, A
    SOMMER, CW
    LIECHTIGALLATI, S
    KRAEMER, R
    HUBBARD, R
    CRYSTAL, RG
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 150 (01) : 207 - 213
  • [3] COLIGAN JE, 1992, CURR PROTOCOLS IMMUN, V6, P10
  • [4] DAVIS PB, 1993, CYSTIC FIBROSIS, P193
  • [5] DEFORGE LE, 1992, J IMMUNOL, V148, P2133
  • [6] DINARELLO CA, 1989, CRIT REV IMMUNOL, V9, P1
  • [7] TUMOR-NECROSIS-FACTOR (CACHECTIN) IS AN ENDOGENOUS PYROGEN AND INDUCES PRODUCTION OF INTERLEUKIN-1
    DINARELLO, CA
    CANNON, JG
    WOLFF, SM
    BERNHEIM, HA
    BEUTLER, B
    CERAMI, A
    FIGARI, IS
    PALLADINO, MA
    OCONNOR, JV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (06) : 1433 - 1450
  • [8] FICK RB, 1991, CLIN RES, V39, pA292
  • [9] CLINICAL MANAGEMENT OF PULMONARY-DISEASE IN CYSTIC-FIBROSIS
    FIEL, SB
    [J]. LANCET, 1993, 341 (8852) : 1070 - 1074
  • [10] INTERLEUKIN-10 REDUCES THE RELEASE OF TUMOR-NECROSIS-FACTOR AND PREVENTS LETHALITY IN EXPERIMENTAL ENDOTOXEMIA
    GERARD, C
    BRUYNS, C
    MARCHANT, A
    ABRAMOWICZ, D
    VANDENABEELE, P
    DELVAUX, A
    FIERS, W
    GOLDMAN, M
    VELU, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) : 547 - 550